Document:

EX-10.4

 Exhibit 10.4 
 DEMANDWARE, INC. 
 Incentive Stock Option Agreement  

Granted Under 2012 Stock Incentive Plan 
  

	1.	Grant of Option. 

 This
agreement evidences the grant by Demandware, Inc., a Delaware corporation (the “Company”), on             , 20__ (the “Grant Date”) to
            , an employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s
2012 Stock Incentive Plan (the “Plan”), a total of              shares (the “Shares”) of common stock, $0.01 par value per share, of the Company
(“Common Stock”) at $         per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on
            , 20__ (the “Final Exercise Date”). 
 It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations
promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under
its terms. 
  

	2.	Vesting Schedule. 

 This
option will become exercisable (“vest”) as to 25% of the original number of Shares on the first anniversary of the Vesting Commencement Date and as to an additional 2.0833% of the original number of Shares at the end of each successive
one-month period following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date. For purposes of this Agreement, “Vesting Commencement Date” shall mean
            , 20__. 
 The right of exercise shall be
cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final
Exercise Date or the termination of this option under Section 3 hereof or the Plan. 
  

	3.	Exercise of Option. 

 (a)
Form of Exercise. Each election to exercise this option shall be in writing, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the
Plan. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional share. 
 (b) Continuous Relationship with the Company Required. Except as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises
this option, is, and has been at all times since the Grant Date, an employee or officer of, or consultant or advisor to, the Company or any parent or subsidiary of the Company as defined in Section 424(e) or (f) of the Code (an
“Eligible Participant”). 

  
 1 

 (c) Termination of Relationship with the Company. If the Participant ceases to be an
Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three (3) months after such cessation (but in no event after the Final Exercise Date),
provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date,
violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate
immediately upon such violation. 
 (d) Exercise Period Upon Death or Disability. If the Participant dies or becomes
disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as specified in paragraph
(e) below, this option shall be exercisable, within the period of one (1) year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), provided that
this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date.

 (e) Termination for Cause. If, prior to the Final Exercise Date, the Participant’s employment is terminated by
the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment. If the Participant is party to an employment or severance agreement with the Company
that contains a definition of “cause” for termination of employment, “Cause” shall have the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean willful misconduct by the Participant or willful
failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar
agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant’s employment shall be considered to have been terminated for Cause if the Company determines, within
thirty (30) days after the Participant’s resignation, that termination for Cause was warranted. 
  

	4.	Tax Matters. 

 (a)
Withholding. No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes
required by law to be withheld in respect of this option. 
 (b) Disqualifying Disposition. If the Participant disposes
of Shares acquired upon exercise of this option within two years from the Grant Date or one year after such Shares were acquired pursuant to exercise of this option, the Participant shall notify the Company in writing of such disposition.

  
 2 

	5.	Transfer Restrictions. 

This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by
operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

 

	6.	Provisions of the Plan. 

This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is
furnished to the Participant with this option. 
 IN WITNESS WHEREOF, the Company has caused this option to be executed under
its corporate seal by its duly authorized officer. This option shall take effect as a sealed instrument. 
  

			
	DEMANDWARE, INC.
		
	By:	 	 
	Name:	 	 
	Title:	 	 

  
 3 

 PARTICIPANT’S ACCEPTANCE 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges
receipt of a copy of the Company’s 2012 Stock Incentive Plan. 
  

			
	 PARTICIPANT:

 

		
	 Address:
	 	 
		 	 

  
 4 

 DEMANDWARE, INC. 

Nonstatutory Stock Option Agreement  
 Granted Under 2012 Stock Incentive Plan 
  

	1.	Grant of Option. 

 This
agreement evidences the grant by Demandware, Inc., a Delaware corporation (the “Company”), on             , 20__ (the “Grant Date”) to
            , an employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s
2012 Stock Incentive Plan (the “Plan”), a total of              shares (the “Shares”) of common stock, $0.01 par value per share, of the Company
(“Common Stock”) at $         per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on
            , 20__ (the “Final Exercise Date”). 
 It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations
promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under
its terms. 
  

	2.	Vesting Schedule. 

 This
option will become exercisable (“vest”) as to 25% of the original number of Shares on the first anniversary of the Vesting Commencement Date and as to an additional 2.0833% of the original number of Shares at the end of each successive
one-month period following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date. For purposes of this Agreement, “Vesting Commencement Date” shall mean , 20__.

 The right of exercise shall be cumulative so that to the extent the option is not exercised in any period to the maximum
extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of this option under Section 3 hereof or the Plan.

  

	3.	Exercise of Option. 

 (a)
Form of Exercise. Each election to exercise this option shall be in writing, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the
Plan. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional share. 
 (b) Continuous Relationship with the Company Required. Except as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises
this option, is, and has been at all times since the Grant Date, an employee, officer or director of, or consultant or advisor to, the Company or any other entity the employees, 

  
 1 

 
officers, directors, consultants, or advisors of which are eligible to receive option grants under the Plan (an “Eligible Participant”). 

(c) Termination of Relationship with the Company. If the Participant ceases to be an Eligible Participant for any reason, then,
except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three (3) months after such cessation (but in no event after the Final Exercise Date), provided that this option shall be
exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or
confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation.

 (d) Exercise Period Upon Death or Disability. If the Participant dies or becomes disabled (within the meaning of
Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as specified in paragraph (e) below, this option shall be
exercisable, within the period of one (1) year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), provided that this option shall be exercisable only to
the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Final Exercise Date. 

(e) Termination for Cause. If, prior to the Final Exercise Date, the Participant’s employment or other relationship with the
Company is terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment or other relationship. If the Participant is party to an
employment, consulting or severance agreement with the Company that contains a definition of “cause” for termination of employment or other relationship, “Cause” shall have the meaning ascribed to such term in such agreement.
Otherwise, “Cause” shall mean willful misconduct by the Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of
any employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant’s employment or
other relationship shall be considered to have been terminated for “Cause” if the Company determines, within thirty (30) days after the Participant’s resignation, that termination for Cause was warranted. 

 

	4.	Withholding. 

 No Shares
will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld
in respect of this option. 
  

	5.	Transfer Restrictions. 

  
 2 

 This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the
Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

 

	6.	Provisions of the Plan. 

This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is
furnished to the Participant with this option. 

  
 3 

 IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate
seal by its duly authorized officer. This option shall take effect as a sealed instrument. 
  

			
	DEMANDWARE, INC.
		
	By:	 	 
	Name:	 	 
	Title:	 	 

  
 4 

 PARTICIPANT’S ACCEPTANCE 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges
receipt of a copy of the Company’s 2012 Stock Incentive Plan. 
  

			
	 PARTICIPANT:

 

		
	 Address:
	 	 
		 	 

  
 5 

 DEMANDWARE, INC. 

Restricted Stock Agreement  
 Granted Under 2012 Stock Incentive Plan 
  

			
	Name of Recipient:	  	  

		
	Number of shares of restricted common stock awarded:	  	  

		
	Grant Date:	  	  

 Demandware, Inc. (the “Company”) has selected you to receive the restricted stock award
described above, which is subject to the provisions of the Company’s 2012 Stock Incentive Plan (the “Plan”) and the terms and conditions contained in this Restricted Stock Agreement. Please confirm your acceptance of this restricted
stock award and of the terms and conditions of this Agreement by signing a copy of this Agreement where indicated below. 
  

			
	DEMANDWARE, INC.
		
	By:	 	 
		 	[insert name and title]

  

	
	Accepted and Agreed:
	
	  
	[insert name of Recipient]

  
 6 

 DEMANDWARE, INC. 

Restricted Stock Agreement 
 The terms and conditions of the award of shares of restricted common stock of the Company (the “Restricted Shares”) made to the Recipient, as set forth on the cover page of this Agreement, are
as follows: 
 1. Issuance of Restricted Shares. 

(a) The Restricted Shares are issued to the Recipient, effective as of the Grant Date (as set forth on the cover page of this Agreement),
in consideration of [employment services rendered and to be rendered] [acceptance of employment and employment services to be rendered by the Recipient to the Company. 
 (b) The Restricted Shares will initially be issued by the Company in book entry form only, in the name of the Recipient. Following the vesting of any Restricted Shares pursuant to Section 2 below,
the Company shall, if requested by the Recipient, issue and deliver to the Recipient a certificate representing the vested Restricted Shares. The Recipient agrees that the Restricted Shares shall be subject to the forfeiture provisions set forth in
Section 3 of this Agreement and the restrictions on transfer set forth in Section 4 of this Agreement. 
 2.
Vesting. 
 (a) Vesting Schedule. Unless otherwise provided in this Agreement or the Plan, the Restricted Shares
shall vest in accordance with the following vesting schedule: [            ]% of the total number of Restricted Shares shall vest on the first anniversary of the Grant Date
and [            ]% of the total number of Restricted Shares shall vest at the end of each successive three-month period following the first anniversary of the Grant Date, through
and including the ____ anniversary of the Grant Date]. Any fractional number of Restricted Shares resulting from the application of the foregoing percentages shall be rounded down to the nearest whole number of Restricted Shares. 

(b) Acceleration of Vesting. Notwithstanding the foregoing vesting schedule, all unvested Restricted Shares shall vest effective
immediately prior to (i) a Reorganization Event involving the liquidation or dissolution of the Company (as defined in the Plan) or (ii) the death or Disability (as defined below) of the Recipient. 

(c) Definitions. For purposes of this Agreement: “Disability” means: (i) if the Recipient’s employment with
the Company is subject to the terms of an employment agreement between the Recipient and the Company, which employment agreement includes a definition of “Disability”, the term “Disability” as used in this Agreement shall have
the meaning set forth in such employment agreement during the period that such employment agreement remains in effect; (ii) in the absence of such an agreement, the term “Disability” as used in the Company’s long-term disability
plan, if any; or (iii) if neither clause (i) nor clause (ii) is applicable, a 

 
physical or mental infirmity which impairs the Recipient’s ability to substantially perform his or her duties for a period of 180 consecutive days. 

3. Forfeiture of Unvested Restricted Shares Upon Employment Termination. 

In the event that the Recipient ceases to be employed by, a director of, or a consultant or advisor to the Company for any reason or no
reason, with or without cause (except as provided in Section 2(b) above), all of the Restricted Shares that are unvested as of the time of such termination from the Company, as well as any Accrued Dividends (as defined below) declared by the
Company with respect to such unvested Restricted Shares) shall be forfeited immediately and automatically to the Company, without the payment of any consideration to the Recipient, effective as of such termination of employment. The Recipient hereby
authorizes the Company to take any actions necessary or appropriate to cancel any certificate(s) representing forfeited Restricted Shares and transfer ownership of such forfeited Restricted Shares to the Company; and if the Company or its transfer
agent requires an executed stock power or similar confirmatory instrument in connection with such cancellation and transfer, the Recipient shall promptly execute and deliver the same to the Company. The Recipient shall have no further rights with
respect to any Restricted Shares, or any Accrued Dividends with respect to such Restricted Shares, that are so forfeited. If the Recipient is employed by a subsidiary of the Company, any references in this Agreement to employment with the Company
shall instead be deemed to refer to employment with such subsidiary. 
 4. Restrictions on Transfer. 

The Recipient shall not sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation of law or otherwise
(collectively “transfer”) any Restricted Shares, or any interest therein, until such Restricted Shares have vested, except that the Recipient may transfer such Restricted Shares: (a) to or for the benefit of any spouse, children,
parents, uncles, aunts, siblings, grandchildren and any other relatives approved by the Compensation Committee (collectively, “Approved Relatives”) or to a trust established solely for the benefit of the Recipient and/or Approved
Relatives, provided that such Restricted Shares shall remain subject to this Agreement (including without limitation the forfeiture provisions set forth in Section 3 and the restrictions on transfer set forth in this Section 4) and
such permitted transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such transferee shall be bound by all of the terms and conditions of this Agreement; or (b) as part of the sale of all
or substantially all of the shares of capital stock of the Company (including pursuant to a merger or consolidation). The Company shall not be required (i) to transfer on its books any of the Restricted Shares which have been transferred in
violation of any of the provisions of this Agreement or (ii) to treat as owner of such Restricted Shares or to pay dividends to any transferee to whom such Restricted Shares have been transferred in violation of any of the provisions of this
Agreement. 
 5. Restrictive Legends. 
 The book entry account reflecting the issuance of the Restricted Shares in the name of the Recipient shall bear a legend or other notation upon substantially the following terms: 

 “These shares of stock are subject to forfeiture provisions and restrictions on
transfer set forth in a certain Restricted Stock Agreement between the corporation and the registered owner of these shares (or his or her predecessor in interest), and such Agreement is available for inspection without charge at the office of the
Secretary of the corporation.” 
 6. Rights as a Shareholder. 

Except as otherwise provided in this Agreement, for so long as the Participant is the registered owner of the Restricted Shares, the
Participant shall have all rights as a shareholder with respect to the Restricted Shares, whether vested or unvested, including, without limitation, any rights to receive dividends and distributions with respect to the Restricted Shares and to vote
the Restricted Shares and act in respect of the Restricted Shares at any meeting of shareholders. [Notwithstanding the foregoing, any dividends, whether in cash, stock or property, declared and paid by the Company with respect to unvested
Restricted Shares (“Accrued Dividends”) shall be paid to the Participant, without interest, only if and when such Restricted Shares vest. 
 7. Provisions of the Plan. 
 This Agreement is subject to the provisions of
the Plan, a copy of which is furnished to the Recipient with this Agreement. As provided in the Plan, upon the occurrence of a Reorganization Event (as defined in the Plan), the rights of the Company hereunder (including the right to receive
forfeited Restricted Shares) shall inure to the benefit of the Company’s successor and, unless the Board determines otherwise, shall apply to the cash, securities or other property which the Restricted Shares were converted into or exchanged
for pursuant to such Reorganization Event in the same manner and to the same extent as they applied to the Restricted Shares under this Agreement. 
 8. Tax Matters. 
 (a) Acknowledgments; Section 83(b) Election.
The Recipient acknowledges that he or she is responsible for obtaining the advice of the Recipient’s own tax advisors with respect to the acquisition of the Restricted Shares and the Recipient is relying solely on such advisors and not on any
statements or representations of the Company or any of its agents with respect to the tax consequences relating to the Restricted Shares. The Recipient understands that the Recipient (and not the Company) shall be responsible for the
Recipient’s tax liability that may arise in connection with the acquisition, vesting and/or disposition of the Restricted Shares and any Accrued Dividends with respect to such Restricted Shares. The Recipient acknowledges that he or she has
been informed of the availability of making an election under Section 83(b) of the Internal Revenue Code, as amended, with respect to the issuance of the Restricted Shares and that the Recipient has decided not to file a Section 83(b)
election. 
 (b) Withholding. The Recipient acknowledges and agrees that the Company has the right to deduct from
payments of any kind otherwise due to the Recipient any federal, state, local or other taxes of any kind required by law to be withheld with respect to the vesting of the Restricted Shares. On each date on which Restricted Shares vest, the Company
shall deliver written notice to the Recipient of the amount of withholding taxes due with respect to the vesting of the Restricted Shares that vest on such date; provided, however, that the total tax

 
withholding cannot exceed the Company’s minimum statutory withholding obligations (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes,
that are applicable to such supplemental taxable income). The Recipient shall satisfy such tax withholding obligations by (i) making a cash payment to the Company on the date of vesting of the Restricted Shares, in the amount of the
Company’s withholding obligation in connection with the vesting of such Restricted Shares; or (ii) by transferring to the Company, on each date on which Restricted Shares vest under this Agreement, such number of Restricted Shares that
vest on such date as have a fair market value (calculated using the last reported sale price of the common stock of the Company on the New York Stock Exchange on the trading date immediately prior to such vesting date) equal to the amount of the
Company’s tax withholding obligation in connection with the vesting of such Restricted Shares. [Alternative 1: To effect such delivery of Restricted Shares, the Recipient hereby authorizes the Company to take any actions necessary
or appropriate to cancel any certificate(s) representing such Restricted Shares and transfer ownership of such Restricted Shares to the Company; and if the Company or its transfer agent requires an executed stock power or similar confirmatory
instrument in connection with such cancellation and transfer, the Recipient shall promptly execute and deliver the same to the Company.] [Alternative 2—If the tender of shares is optional: To effect such delivery of Restricted
Shares, the Recipient shall deliver a written notice to the Company stating that a specified number of Restricted Shares registered to the Recipient in book entry form are thereby transferred to the Company. Alternative 2—If the tender of
shares is mandatory: Such delivery of Restricted Shares to the Company shall be deemed to happen automatically, without any action required on the part of the Recipient, and the Company is hereby authorized to take such actions as are necessary
to effect such delivery.]] 
 9. Miscellaneous. 
 (a) Authority of Compensation Committee. In making any decisions or taking any actions with respect to the matters covered by this Agreement, the Compensation Committee shall have all of the
authority and discretion, and shall be subject to all of the protections, provided for in the Plan. All decisions and actions by the Compensation Committee with respect to this Agreement shall be made in the Compensation Committee’s discretion
and shall be final and binding on the Recipient. 
 (b) No Right to Continued Employment. The Recipient acknowledges and
agrees that, notwithstanding the fact that the vesting of the Restricted Shares is contingent upon his or her continued employment by the Company, this Agreement does not constitute an express or implied promise of continued employment or confer
upon the Recipient any rights with respect to continued employment by the Company. 
 (c) Governing Law. This Agreement
shall be construed, interpreted and enforced in accordance with the internal laws of the State of Delaware without regard to any applicable conflicts of laws provisions. 
 (d) Recipient’s Acknowledgments. The Recipient acknowledges that he or she has read this Agreement, has received and read the Plan, and understands the terms and conditions of this Agreement
and the Plan. 

 DEMANDWARE, INC. 

Nonstatutory Stock Option Agreement for German Participant  
 Granted Under 2012 Stock Incentive Plan 
  

	1.	Grant of Option. 

 This
agreement evidences the grant by Demandware, Inc., a Delaware corporation (the “Company”), on             , 20__ (the “Grant Date”) to
            , a German resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part,
on the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”) notably Section 5 thereof, a total of              shares (the
“Shares”) of common stock, $0.01 par value per share, of the Company (“Common Stock”) at $         per Share. Unless earlier terminated, this option shall expire at 5:00 p.m.,
Eastern time, on             , 20__ (the “Final Exercise Date”). 
 It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations
promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under
its terms. 
  

	2.	Vesting Schedule. 

 This
option will become exercisable (“vest”) as to 25% of the original number of Shares on the first anniversary of the Vesting Commencement Date and as to an additional 2.0833% of the original number of Shares at the end of each successive
one-month period following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date. For purposes of this Agreement, “Vesting Commencement Date” shall mean
            , 20__. 
 The right of exercise shall be
cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final
Exercise Date or the termination of this option under Section 3 hereof or the Plan. 
  

	3.	Exercise of Option. 

 (a)
Form of Exercise. Each election to exercise this option shall be in writing, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the
Plan. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional share. 
 (b) Continuous Relationship with the Participant’s Employing Entity Required. Except as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at
the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee, officer or director of, or consultant or advisor to, his or her employing 

  
 1 

 
entity or any other entity the employees, officers, directors, consultants, or advisors of which are eligible to receive option grants under the Plan (an “Eligible Participant”).

 (c) Termination of Relationship with the Participant’s Employing Entity. If the Participant ceases to be an
Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three (3) months after such cessation (but in no event after the Final Exercise Date),
provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date,
violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and his or her employing entity, the right to exercise this option shall
terminate immediately upon such violation. 
 (d) Exercise Period Upon Death or Disability. If the Participant dies or
becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and his or her employing entity has not terminated such relationship for “cause” as
specified in paragraph (e) below, this option shall be exercisable, within the period of one (1) year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee),
provided that this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the
Final Exercise Date. 
 (e) Termination for Cause. If, prior to the Final Exercise Date, the Participant’s
employment or other relationship with his or her employing entity is terminated by his or her employing entity for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of
employment or other relationship. If the Participant is party to an employment, consulting or severance agreement with his or her employing entity that contains a definition of “cause” for termination of employment or other relationship,
“Cause” shall have the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean willful misconduct by the Participant or willful failure by the Participant to perform his or her responsibilities to his or
her employing entity (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and his or her employing
entity), as determined by his or her employing entity, which determination shall be conclusive. The Participant’s employment or other relationship shall be considered to have been terminated for “Cause” if his or her employing entity
determines, within thirty (30) days after the Participant’s resignation, that termination for Cause was warranted. 
  

	4.	Tax Matters. 

 (a)
Withholding. No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company or his or her employing entity, or makes provision satisfactory to the Company or his or her employing entity
for payment of, any federal or state taxes or pays to the employing entity, or makes provision satisfactory to the employing entity for payment of German salary income tax and social security and pension contributions of any kind required or allowed
by law to be withheld in respect of this option. The employing entity may request an advance cash payment to satisfy German salary tax and social security and 

  
 2 

 
pension withholding requirements. The Participant is required to immediately inform his or her employing entity of the fact and date of any exercise of this option and, notwithstanding this
requirement, the Participant consents to the Company informing his or her employing entity of the same. 
 (b) Indemnity.
The Participant hereby indemnifies the Company, his or her employing entity and each parent or subsidiary of the Company against all and any Tax Liabilities (including, to the maximum extent permitted by law, employer social security and pension
contributions) which arise or may arise in connection with this option and the Common Stock issued or transferred to the Participant pursuant to the exercise of this option in whole or in part. 

(c) The Participant has reviewed with his own tax advisors the tax consequences of the grant, vesting and exercise of this option and the
transactions contemplated by this Agreement. The Participant is relying solely on such advisors and not on any statements or representatives of the Company, his or her employing entity of any agent thereof. 

 

	5.	Transfer Restrictions. 

This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by
operation of law, except by will or the laws of descent and distribution applicable to the Participant, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

 

	6.	Provisions of the Plan. 

This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is
furnished to the Participant with this option. 
  

	7.	No Right to Employment etc. 

 (a) The grant of options under the Plan is made at the discretion of the Company and the Plan may be suspended or terminated by the Company at any time. The grant of an option in one year or at one time
does not in any way entitle the Participant to an option grant in the future. The Plan is wholly discretionary and is not to be considered part of the Participant’s normal or expected compensation subject to severance, resignation, redundancy
or similar compensation. The value of the option is an extraordinary item of compensation which is outside the scope of the Participant’s employment contract (if any). 
 (b) Nothing in this agreement or the Plan shall confer upon the Participant any right to continue in service for any period of specific duration or interfere with or otherwise restrict in any way the
rights of the Company or the Participant’s employing entity or of the Participant, which rights are hereby expressly reserved by each, to terminate the Participant’s service. 

(c) The rights and obligations of the Participant under the terms of his office or employment with his or her employing entity, any past
or present subsidiary, or associated or affiliate company of the Company shall not be affected by his participation in the Plan or the grant of this option or any right which he may have to participate therein, and the Participant hereby waives all
and any rights to compensation or damages in consequence of the termination 

  
 3 

 
of his office or employment with any such company for any reasons whatsoever (whether lawful or unlawful and including, without prejudice to the generality of the foregoing, in circumstances
giving rise to a claim for wrongful dismissal) insofar as those rights arise or may arise from his ceasing to have rights under or being entitled to exercise this option as a result of such termination, or from the loss or diminution in value of
such rights or entitlements. 
  

	8.	Data Privacy. 

 The
Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of his personal data as described in this Agreement by and among, as applicable, his or her employing entity or contracting
party and the Company for the exclusive purpose of implementing, administering and managing his participation in the Plan. 

The Participant understands that the Company holds certain personal information about him, including, but not limited to, his name, home
address and telephone number, work location and phone number, date of birth, hire date, details of all awards or any other entitlement to shares awarded, cancelled, exercised, vested, unvested or outstanding in the Participant’s favor, for the
purpose of implementing, administering and managing the Plan (“Personal Data”). The Participant understands that Personal Data may be transferred to any third parties assisting in the implementation, administration and management of the
Plan, that these recipients may be located in the Participant’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Participant’s country. The Participant understands
that he may request a list with the names and addresses of any potential recipients of the Personal Data by contacting his local human resources representative. The Participant authorizes the recipients to receive, possess, use, retain and transfer
the Personal Data, in electronic or other form, for the purposes of implementing, administering and managing his participation in the Plan. The Participant understands that Personal Data will be held only as long as is necessary to implement,
administer and manage his participation in the Plan. The Participant understands that he may, at any time, view Personal Data, request additional information about the storage and processing of Personal Data, require any necessary amendments to
Personal Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his local human resources representative. The Participant understands, however, that refusing or withdrawing his consent may affect his
ability to participate in the Plan. For more information on the consequences of Participant’s refusal to consent or withdrawal of consent, the Participant understands that he may contact his local human resources representative. 

 

	9.	Governing Law. 

 This
Agreement shall be construed, interpreted and enforced in accordance with the internal laws of the State of Delaware without regard to any applicable conflicts of laws. 

  
 4 

 IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate
seal by its duly authorized officer. This option shall take effect as a sealed instrument. 
  

			
	DEMANDWARE, INC.
		
	By:	 	 
	Name:	 	 
	Title:	 	 

  
 19 

 PARTICIPANT’S ACCEPTANCE 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges
receipt of a copy of the Company’s 2012 Stock Incentive Plan. 
  

			
	 PARTICIPANT:

 

		
	 Address:
	 	 
		 	 

  
 6 

 DEMANDWARE, INC. 

Nonstatutory Stock Option Agreement for UK Participant  
 Granted Under 2012 Stock Incentive Plan 
  

	1.	Grant of Option. 

 This
agreement evidences the grant by Demandware, Inc., a Delaware corporation (the “Company”), on             , 20__ (the “Grant Date”) to
            , a UK resident employee, consultant or director of a subsidiary to the Company (the “Participant”), of an option to purchase, in whole or in part, on
the terms provided herein and in the Company’s 2012 Stock Incentive Plan (the “Plan”), a total of              shares (the “Shares”) of common stock,
$0.01 par value per share, of the Company (“Common Stock”) at $         per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on
            , 20__ (the “Final Exercise Date”). 
 It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations
promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under
its terms. 
  

	2.	Vesting Schedule. 

 This
option will become exercisable (“vest”) as to 25% of the original number of Shares on the first anniversary of the Vesting Commencement Date and as to an additional 2.0833% of the original number of Shares at the end of each successive
one-month period following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date. For purposes of this Agreement, “Vesting Commencement Date” shall mean
            , 20__. 
 The right of exercise shall be
cumulative so that to the extent the option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final
Exercise Date or the termination of this option under Section 3 hereof or the Plan. 
  

	3.	Exercise of Option. 

 (a)
Form of Exercise. Each election to exercise this option shall be in writing, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the
Plan. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option may be for any fractional share. 
 (b) Continuous Relationship with the Participant’s Employing Entity Required. Except as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at
the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee, officer or director of, or consultant or advisor to, his or her employing 

  
 1 

 
entity or any other entity the employees, officers, directors, consultants, or advisors of which are eligible to receive option grants under the Plan (an “Eligible Participant”).

 (c) Termination of Relationship with the Participant’s Employing Entity. If the Participant ceases to be an
Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three (3) months after such cessation (but in no event after the Final Exercise Date),
provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date,
violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and his or her employing entity, the right to exercise this option shall
terminate immediately upon such violation. 
 (d) Exercise Period Upon Death or Disability. If the Participant dies or
becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and his or her employing entity has not terminated such relationship for “cause” as
specified in paragraph (e) below, this option shall be exercisable, within the period of one (1) year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee),
provided that this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the
Final Exercise Date. 
 (e) Termination for Cause. If, prior to the Final Exercise Date, the Participant’s
employment or other relationship with his or her employing entity is terminated by his or her employing entity for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of
employment or other relationship. If the Participant is party to an employment, consulting or severance agreement with his or her employing entity that contains a definition of “cause” for termination of employment or other relationship,
“Cause” shall have the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean willful misconduct by the Participant or willful failure by the Participant to perform his or her responsibilities to his or
her employing entity (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and his or her employing
entity), as determined by his or her employing entity, which determination shall be conclusive. The Participant’s employment or other relationship shall be considered to have been terminated for “Cause” if his or her employing entity
determines, within thirty (30) days after the Participant’s resignation, that termination for Cause was warranted. 
  

	4.	Tax Matters. 

 (a)
Withholding. No Shares will be issued pursuant to the exercise of this option unless and until the Participant pays to the Company or his or her employing entity, or makes provision satisfactory to the Company or his or her employing entity
for payment of, any federal or state taxes, UK income tax and national insurance contributions of any kind required or allowed by law to be withheld in respect of this option or which the Participant has provided an

  
 2 

 
indemnity or has agreed or elected to bear including without limitation any employer and employee national insurance contributions (together “Tax Liabilities”). 

(b) Indemnity. The Participant hereby indemnifies the Company, his or her employing entity and each parent or subsidiary of the
Company against all and any Tax Liabilities (including, to the maximum extent permitted by law, employer national insurance contributions) which arise or may arise in connection with this option and the Common Stock issued or transferred to the
Participant pursuant to the exercise of this option in whole or in part. 
 (c) Employer NIC Joint Election. Unless the
Company permits otherwise, this option may not be exercised unless and until the Company has received from the Participant a duly completed joint election with the Company, his or her employing entity or other company (in the form and manner
prescribed by the Company from time to time) to the effect that the Participant will become liable, so far as permissible by law, for the whole of any employer national insurance contributions which may arise in connection with this option and the
Common Stock which is or may be acquired on the exercise of this option. 
  

	5.	Transfer Restrictions. 

This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by
operation of law, except by will or the laws of descent and distribution applicable to the Participant, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

 

	6.	Provisions of the Plan. 

This option is subject to the provisions of the Plan (including the provisions relating to amendments to the Plan), a copy of which is
furnished to the Participant with this option. 
  

	7.	No Right to Employment etc. 

 (a) The grant of options under the Plan is made at the discretion of the Company and the Plan may be suspended or terminated by the Company at any time. The grant of an option in one year or at one time
does not in any way entitle the Participant to an option grant in the future. The Plan is wholly discretionary and is not to be considered part of the Participant’s normal or expected compensation subject to severance, resignation, redundancy
or similar compensation. The value of the option is an extraordinary item of compensation which is outside the scope of the Participant’s employment contract (if any). 
 (b) Nothing in this agreement or the Plan shall confer upon the Participant any right to continue in service for any period of specific duration or interfere with or otherwise restrict in any way the
rights of the Company or the Participant’s employing entity or of the Participant, which rights are hereby expressly reserved by each, to terminate the Participant’s service. 

(c) The rights and obligations of the Participant under the terms of his office or employment with his or her employing entity, any past
or present subsidiary, or associated or affiliate company of the Company shall not be affected by his participation in the Plan or the grant of this option or any right which he may have to participate therein, and the Participant hereby waives all
and any rights to compensation or damages in consequence of the termination 

  
 3 

 
of his office or employment with any such company for any reasons whatsoever (whether lawful or unlawful and including, without prejudice to the generality of the foregoing, in circumstances
giving rise to a claim for wrongful dismissal) insofar as those rights arise or may arise from his ceasing to have rights under or being entitled to exercise this option as a result of such termination, or from the loss or diminution in value of
such rights or entitlements. 
  

	8.	Data Privacy. 

 The
Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of his personal data as described in this Agreement by and among, as applicable, his or her employing entity or contracting
party and the Company for the exclusive purpose of implementing, administering and managing his participation in the Plan. 

The Participant understands that the Company holds certain personal information about him, including, but not limited to, his name, home
address and telephone number, work location and phone number, date of birth, hire date, details of all awards or any other entitlement to shares awarded, cancelled, exercised, vested, unvested or outstanding in the Participant’s favor, for the
purpose of implementing, administering and managing the Plan (“Personal Data”). The Participant understands that Personal Data may be transferred to any third parties assisting in the implementation, administration and management of the
Plan, that these recipients may be located in the Participant’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Participant’s country. The Participant understands
that he may request a list with the names and addresses of any potential recipients of the Personal Data by contacting his local human resources representative. The Participant authorizes the recipients to receive, possess, use, retain and transfer
the Personal Data, in electronic or other form, for the purposes of implementing, administering and managing his participation in the Plan. The Participant understands that Personal Data will be held only as long as is necessary to implement,
administer and manage his participation in the Plan. The Participant understands that he may, at any time, view Personal Data, request additional information about the storage and processing of Personal Data, require any necessary amendments to
Personal Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his local human resources representative. The Participant understands, however, that refusing or withdrawing his consent may affect his
ability to participate in the Plan. For more information on the consequences of Participant’s refusal to consent or withdrawal of consent, the Participant understands that he may contact his local human resources representative. 

 

	9.	Governing Law. 

 This
Agreement shall be construed, interpreted and enforced in accordance with the internal laws of the State of Delaware without regard to any applicable conflicts of laws. 

  
 4 

 IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate
seal by its duly authorized officer. This option shall take effect as a sealed instrument. 
  

			
	DEMANDWARE, INC.
		
	By:	 	 
	Name:	 	 
	Title:	 	 

  
 5 

 PARTICIPANT’S ACCEPTANCE 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges
receipt of a copy of the Company’s 2012 Stock Incentive Plan. 
  

			
	 PARTICIPANT:

 

		
	 Address:
	 	 
		 	 

  
 6 

 Stock Option Agreement 

under the Demandware, Inc. 
 2012 Stock Incentive Plan and Sub-Plan for France 
 We are pleased to inform you that the
Board, acting under the authorization given by the shareholders to establish the Demandware Inc. 2012 Stock Incentive Plan and sub-plans, granted you <> stock options to purchase to DEMANDWARE, Inc.’s shares, at the price of <>
dollars per unit in the context of Article L. 225-177 of the French Commercial Code. 
  

			
	Name of Optionee:	  	________________(the “Optionee”)
		
	No. of Option Shares:	  	______ Shares of Common Stock
		
	Grant Date:	  	_______________ (the “Grant Date”)
		
	Expiration Date:	  	______________ (the “Expiration Date”)
		
	Vesting Commencement Date:	  	______________ (the “Vesting Commencement Date”)
		
	Option Exercise Price/Share:	  	______________ (the “Option Exercise Price”)

 Pursuant to the Demandware, Inc. 2012 Incentive Plan (the “Plan”), and the Sub-Plan for France
(the ‘Sub-Plan’), Demandware, Inc., a Delaware corporation (together with all successors thereto, the “Company”), hereby grants to the Optionee, who is an officer, employee, director of the Company or any of its Subsidiaries, a
French Qualified option (the “Stock Option”) to purchase on or prior to the Expiration Date, or such earlier date as is specified herein, all or any part of the number of shares of Common Stock, par value $0.01 per share (“Common
Stock”), of the Company indicated above (the “Option Shares,” and such shares once issued shall be referred to as the “Issued Shares”), at the Option Exercise Price per share, subject to the terms and conditions set forth in
this Stock Option Agreement (this “Agreement”) and in the Sub-Plan. It is intended that this Stock Option shall qualify for favorable income tax and social tax treatment under Sections L.225 – 177 to L. 225 – 186 of the French
Commercial Code. The Optionee acknowledges receipt of a copy of the Plan and the Sub-Plan and represents that he or she is familiar with the terms and provisions thereof, and accepts this Stock Option subject to all of the terms and provisions
thereof. 
 1. Definitions. For the purposes of this Agreement, the following terms shall have the following
respective meanings. All capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Plan and the Sub-Plan. 
 An “Affiliate” of any Person means a Person that directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with the first mentioned
Person. A Person shall be deemed to control another Person if such first Person possesses directly or indirectly the power to direct, or cause the direction of, the management and policies of the second Person, whether through the ownership of
voting securities, by contract or otherwise. 

  
 1 

 “Bankruptcy” shall mean (i) the filing of a voluntary petition under
any bankruptcy or insolvency law, or a petition for the appointment of a receiver or the making of an assignment for the benefit of creditors, with respect to the Optionee, or (ii) the Optionee being subjected involuntarily to such a petition
or assignment or to an attachment or other legal or equitable interest with respect to the Optionee’s assets, which involuntary petition or assignment or attachment is not discharged within 60 days after its date, and (iii) the Optionee
being subject to a transfer of the Stock Option or the Issued Shares by operation of law (including by divorce, even if not insolvent), except by reason of death. 
 “Cause” shall mean a vote of the Board resolving that the Optionee should be dismissed as a result of: 
 (i) dishonest acts of the Optionee with respect to the Company or any Affiliate of the Company; 
 (ii) the commission by or indictment of the Optionee for (A) a felony or (B) any misdemeanor involving moral turpitude, deceit, dishonesty or fraud (“indictment,” for these purposes,
meaning an indictment, probable cause hearing or any other procedure pursuant to which an initial determination of probable or reasonable cause with respect to such offense is made); 

(iii) Optionee’s breach of his duty of loyalty to the Company or any Affiliate of the Company or any act or omission by the Optionee
constituting unethical business practices; 
 (iv) failure to perform to the reasonable judgment of the Board the
Optionee’s duties and responsibilities assigned or delegated to such Optionee; 
 (v) gross negligence of the Optionee,
including but not limited to continued absences after written notice given to the Optionee by the Board; 
 (vi) willful
misconduct or insubordination of the Optionee with respect to the Company or any Affiliate of the Company, including but not limited to repeated unwarranted threats of resignation; or 

(vii) breach by the Optionee of any of the Optionee’s material obligations under any noncompetition, nondisclosure and developments
agreement executed by the Optionee in favor of the Company or any Affiliate of the Company. 
 “Person” shall
mean any individual, corporation, partnership (limited or general), limited liability company, limited liability partnership, association, trust, joint venture, unincorporated organization or any similar entity. 

“Sale Event” shall mean, regardless of form thereof, consummation of (i) the sale of all or substantially all of
the assets of the Company on a consolidated basis to an unrelated person or entity, (ii) a merger, reorganization or consolidation in which the outstanding shares of 

  
 2 

 
Stock are converted into or exchanged for securities of the successor entity and the holders of the Company’s outstanding voting power immediately prior to such transaction do not own a
majority of the outstanding voting power of the successor entity immediately upon completion of such transaction, (iii) the sale of all or a majority of the outstanding capital stock of the Company to an unrelated person or entity or
(iv) any other transaction in which the owners of the Company’s outstanding voting power immediately prior to such transaction do not own at least a majority of the outstanding voting power of the successor entity immediately upon
completion of the transaction; provided, however, that “Sale Event” shall not include any financing transaction of the Company (whether public or private) that would otherwise be and/or trigger a “Sale Event” under
(iii) and/or (iv) above. 
 “Subsidiary” shall mean any corporation (other than the Company) in any
unbroken chain of corporations or other entities beginning with the Company if each of the corporations (other than the last corporation in the unbroken chain) owns stock or other interests possessing 50 percent or more of the total combined voting
power of all classes of stock or in one of the other corporations in the chain. 
 2. Vesting, Exercisability and
Termination. 
 (a) No portion of this Stock Option may be exercised until such portion shall have vested. 

(b) Except as set forth below and in Section 6, and subject to the determination of the Board in its sole discretion to accelerate
the vesting schedule hereunder, this Stock Option shall be vested and exercisable with respect to: (i) twenty-five percent (25%) of the Option Shares on the first anniversary of the Vesting Commencement Date; and (ii) 2.0833% of the
Option Shares at the end of each successive one-month period following the first anniversary of the Vesting Commencement Date until the fourth anniversary of the Vesting Commencement Date. 

(c) Notwithstanding anything herein to the contrary, but without limitation of Section 6, in the event that this Stock Option is
assumed or continued by the Company or its successor entity in the sole discretion of the parties to a Sale Event and thereafter remains in effect following such Sale Event as contemplated by Section 6. 

(d) Termination. Except as may otherwise be provided by the Board, if the Optionee’s employment with the Company or a
Subsidiary is terminated, the period within which to exercise this Stock Option may be subject to earlier termination as set forth below: 
 (i) Termination of the employment contract or executive position by way of the Beneficiary’s retirement, the right to exercise the Options remains open for three (3) months following the date of
the termination of the employment contract or executive position, 
 (ii) Invalidity of the
2nd and 3rd category under Article L.341-4 of the French Social Security Code,
the right to exercise the Options remains open for twelve (12) months following the date of invalidity, 

  
 3 

 (iii) On the death of the Beneficiary, the right to exercise the Options
remains open to the Beneficiary’s heirs for six (6) months following the date of death as stated in section 5. hereafter, 
 (iv) Other Termination. If the Optionee’s employment terminates for any reason other than death, disability or retirement, and unless otherwise determined by the Board, this Stock Option may
be exercised, to the extent exercisable on the date of termination, for a period of three (3) months from the date of termination or until the Expiration Date, if earlier, provided, however, if the Optionee’s employment is
terminated for Cause, this Stock Option shall terminate immediately upon the date of such termination. 
 For purposes hereof,
the Board’s determination of the reason for termination of the Optionee’s employment shall be conclusive and binding on the Optionee and his or her representatives or legatees. Any portion of the Stock Option that is not exercisable on the
date of termination of the employment shall terminate immediately and be null and void. 
 3. Exercise of Stock
Option. 
 (a) The Optionee may exercise this Stock Option only in the following manner: Prior to the Expiration Date
(subject to Section 2(c) and Section 6), the Optionee may deliver a Stock Option exercise notice (an “Exercise Notice”) in the form of Appendix A hereto indicating his or her election to purchase some or all of the
Option Shares with respect to which this Stock Option is exercisable at the time of such notice. Such notice shall specify the number of Option Shares to be purchased. Payment of the purchase price may be made by one or more of the methods described
below. Payment instruments will be received subject to collection. 
 (i) in cash, by certified or bank check, or
other instrument acceptable to the Board in U.S. funds payable to the order of the Company in an amount equal to the purchase price of such Option Shares; or 
 (ii) as permitted by the 2012 Stock Incentive Plan, an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and
any required tax withholding or delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and
any required tax withholding. 
 (b) Certificates for the Option Shares so purchased will be issued and delivered to the
Optionee upon compliance to the satisfaction of the Board with all requirements under applicable laws or regulations in connection with such issuance. Until the Optionee shall have complied with the requirements hereof and of the Plan and the
Sub-Plan, the Company shall be under no obligation to issue the Option Shares subject to this Stock Option, and the determination of the Board as to such compliance shall be final and binding on the Optionee. The Optionee shall not be deemed to be
the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to this Stock Option unless and until this Stock Option shall have been exercised pursuant to the terms hereof, the Company shall have issued
and 

  
 4 

 
delivered the Issued Shares to the Optionee, and the Optionee’s name shall have been entered as a stockholder of record on the books of the Company. Thereupon, the Optionee shall have full
dividend and other ownership rights with respect to such Issued Shares, subject to the terms of this Agreement. 
 (c)
Notwithstanding any other provision hereof or of the Plan or the Sub-Plan, no portion of this Stock Option shall be exercisable after the Expiration Date. 
 (d) Shares issued on exercise of an Option are unassignable for a period of four (4) years from the Option Grant Date, although this share retention period may not exceed three (3) years from
the date of exercise of the Option (hereafter, the “Holding Period “). 
 (e) On expiry of the Holding Period, the
Shares are transferable in accordance with provisions of the Company by-laws, and any other act agreed by the Company’s shareholders. 
 4. Incorporation of Plan and the Sub-Plan. Notwithstanding anything herein to the contrary, this Stock Option shall be subject to and governed by all the terms and conditions of the Plan and
the Sub-Plan for France. 
 5. Transferability of Stock Option. This Agreement is personal to the Optionee and is
not transferable by the Optionee in any manner other than by inheritance. The Stock Option may be exercised during the Optionee’s lifetime only by the Optionee subject to provisions of Section 2 and Section 3 of the Agreement.

 In the event of death of the beneficiary during the exercise period of the options, the beneficiary’s heirs will have a
period of six (6) months following the date of death, to exercise the option. Upon expiry of this period the option will be null and void. 
 6. Effect of Certain Transactions. In the case of a Sale Event, this Stock Option shall terminate upon the effective time of any such Sale Event unless provision is made in connection with
such transaction in the sole discretion of the parties thereto for the continuation or assumption of this Stock Option heretofore granted, or the substitution of this Stock Option with a new Stock Option of the successor entity or a parent thereof,
with such adjustment as to the number and kind of shares and the per share exercise prices as such parties shall agree. In the event of such termination, the Optionee shall be permitted, for a specified period of time prior to the consummation of
the Sale Event as determined by the Board, to exercise all portions of the Stock Option which are then exercisable. 
 7.
Withholding Taxes. No Shares will be issued pursuant to the exercise of this option unless and until the Optionee pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding
taxes required by law to be withheld in respect of this option. 

  
 5 

 8. Miscellaneous Provisions. 

(a) Adjustments for Changes in Capital Structure. Where there is an increase or change in the Company’s share capital, and
more generally where one of the events provided for under Article L.225-181 of the French Commercial Code occurs, the Board has the discretion to determine that an adjustment may be made to the number and/or purchase price of Shares, in accordance
with the provisions of Articles R.225-137 of the French Commercial Code. Notification of said adjustment shall be made to the Beneficiaries. 
 (b) Change and Modifications. This Agreement may not be orally changed, modified or terminated, nor shall any oral waiver of any of its terms be effective. This Agreement may be changed, modified
or terminated only by an agreement in writing signed by the Company and the Optionee. 
 (c) Governing Law. This
Agreement shall be governed by and construed in accordance with the laws of Delaware without regard to conflict of law principles. 
 (d) Headings. The headings are intended only for convenience in finding the subject matter and do not constitute part of the text of this Agreement and shall not be considered in the interpretation
of this Agreement. 
 (e) Saving Clause. If any provision(s) of this Agreement shall be determined to be illegal or
unenforceable, such determination shall in no manner affect the legality or enforceability of any other provision hereof. 
 (f)
Notices. All notices, requests, consents and other communications shall be in writing and be deemed given when delivered personally, by telex or facsimile transmission or when received if mailed by first class registered or certified mail,
postage prepaid. Notices to the Company or the Optionee shall be addressed as set forth underneath their signatures below, or to such other address or addresses as may have been furnished by such party in writing to the other. 

(g) Benefit and Binding Effect. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and
their heirs. The Company has the right to assign this Agreement, and such assignee shall become entitled to all the rights of the Company hereunder to the extent of such assignment. 

(h) Counterparts. For the convenience of the parties and to facilitate execution, this Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same document. 

[SIGNATURE PAGE FOLLOWS] 

  
 6 

 The foregoing Agreement is hereby accepted and the terms and conditions thereof hereby
agreed to by the undersigned as of the date first above written. 
  

			
	DEMANDWARE, INC.
		
	By:	 	 
		 	 Name:

Title:

	
	Address:

  
 The foregoing Agreement is
hereby accepted and the terms and conditions thereof hereby agreed to by the undersigned as of the date first above written. 
  

			
	 OPTIONEE:
  

 
 Name:

	
	Address:
	  
  

	  
  

	  
  

  
  

 

  
 7 

 Appendix A 
 NOTICE OF STOCK OPTION EXERCISE 
 Date: ____________1 
 Demandware, Inc. 
 5 Wall Street 
 Burlington, MA 01803 
 Attention: Treasurer 

Dear Sir or Madam: 
 I am the
holder of a Nonstatutory Stock Option granted to me under the Demandware, Inc. (the “Company”) 2012 Stock Incentive Plan and the SubPlan for France on __________2 for the purchase of __________3 shares of Common Stock of the Company at a purchase price of $__________4 per share. 

I hereby exercise my option to purchase _________5 shares of Common Stock (the “Shares”), for which I have enclosed __________6 in the amount of ________7. Please register my stock certificate as follows: 

 

					
	Name(s):	  	_______________________8	  	
			
	Address:	  	_______________________	  	
			
		  	_______________________	  	
			
	Tax I.D. #:	  	_______________________	  	

  
  

	
	Very truly yours,
	
	  
	(Signature)

  

	1 	Enter the date of exercise. 

	2 	Enter the date of grant. 

	3 	Enter the total number of shares of Common Stock for which the option was granted. 

	4 	Enter the option exercise price per share of Common Stock. 

	5 	Enter the number of shares of Common Stock to be purchased upon exercise of all or part of the option. 

	6 	Enter (i) “cash”, (ii) “personal check,” or (iii) as permitted by the 2012 Stock Incentive Plan, an irrevocable and unconditional
undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and any required tax withholding or delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions
to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and any required tax withholding. 

	7 	Enter the dollar amount (exercise price per share times the number of shares to be purchased). 

	8 	Enter name to appear on stock certificate. 

  
 8EX-10.7

 Exhibit 10.7 

 

	
	 Confidential Materials omitted and filed separately with the

Securities and Exchange Commission. Double asterisks denote omissions.

 EXCLUSIVE DISTRIBUTION AGREEMENT 

(for Smartlipo MPX and SLT II Laser System) 
 THIS AGREEMENT is made by and between El. En. S.p.A., a company organized under the laws of Italy whose address is Via Baldanzese 17, 50041 Calenzano, Firenze, Italy (hereafter referred to as “El
En”), and Cynosure, Inc., a Delaware corporation whose address is 5 Carlisle Road Westford MA 01886 (hereinafter referred to as “Cynosure”). This Agreement shall be effective as of October 26, 2012 (hereinafter the
“Effective Date”). (Both El En and Cynosure are sometimes collectively referred to as the “Parties”, and each may be referred to in the singular as a “Party”). 

The Parties hereby agree to the following: 
  

	1.	DEFINITIONS 

 The terms
used in this Agreement shall have the following meaning: 
 1.1. “Territory” shall mean worldwide. 

1.2 The “Patent Rights” shall mean the issued, valid claims of U.S. Pat. No. 5,954,710 and U.S. Pat. No. 6,206,873
and any issued, valid claims of any continuations, continued prosecution applications or divisional or corresponding foreign applications thereof. “Patent Rights” shall also include any reissue, reexamination or extension of U.S. Pat.
No. 5,954,710 and U.S. Pat. No. 6,206,873. 
 1.3 “Products” shall mean (a) Smartlipo MPX meeting the
specifications set forth in Exhibit A, and (b) the SLT II Laser System meeting the specifications set forth in Exhibit A as the essential component of the systems sold under the trade names Smartlipo Triplex and Cellulaze (hereinafter “the
Systems incorporating the SLT II Laser system”) with specifications set forth in Exhibit A1 to this Agreement together with any replacement thereto or modification or improvement thereof developed, owned or licensed by El En. The term
“Product” may be modified from time to time by written amendment to this Agreement executed by the parties hereto whereby the parties agree to include additional El En products in Exhibit A. 

1.4 “Affiliate” shall mean, with respect to either party, a corporation or entity that directly or indirectly through one or
more intermediaries controls, or is controlled by, or is under common control with such party. 
 1.5 “Trademark(s)”
shall mean the trademark “Smartlipo” which is the subject of U.S. Trademark Registration No. U.S. 3,436,485, and any other marks necessary or useful in connection with the activities contemplated by this Agreement, or as otherwise
designated by El En, including trademarks that are the subject of trademark applications or registrations, filed or pending during the term of the Agreement within the Territory, including any renewals thereof. 

  
 1 

	2.	APPOINTMENT AND ACCEPTANCE 

2.1 Subject to Cynosure’s compliance with all the terms of this Agreement, El En hereby appoints Cynosure as its exclusive
distributor for the marketing, sale and delivery of the Products in the Territory, and Cynosure accepts such appointment. 
 2.2
This appointment of Cynosure as El En’s distributor for the Products in the Territory is an exclusive appointment. During the term of this Agreement and so long as Cynosure is not then in default under this Agreement, El En shall not distribute
the Products , including the SLT II laser system, or appoint any other distributor for the Products ,including the SLT II laser system in the Territory. Notwithstanding the foregoing, nothing herein shall prevent El En from engaging in the
marketing, distribution or sale of products which do not incorporate the Product anywhere in the Territory. Moreover El En may continue to engage in the marketing, distribution or sale worldwide (U.S. excluded) of any first generation Smartlipo
systems, and modification or improvement thereof, provided that such Smartlipo systems sold by El En do not incorporate elements of technologies owned by Cynosure that are incorporated in a Smartlipo MPX, Smartlipo Triplex and/or Cellulaze product
and/or subject to U.S. patent n. 5746735. 
 2.3 This appointment shall automatically terminate upon the expiration or
termination of this Agreement. 
 2.4 Cynosure shall have the right, without the prior written consent of El En, to appoint
sub-distributors or sub-dealers to sell the Products in the Territory. Notwithstanding the foregoing, should El.En. reasonably object to any such appointment, Cynosure shall refrain therefrom. 

2.5 Cynosure has not paid any fee or other consideration for the rights established by this Agreement. Neither this Agreement nor any
right granted by this Agreement is a property right. Neither this Agreement nor any right or responsibility under this Agreement may be transferred, assigned, delegated or sold by Cynosure or by operation of law. 

2.6 No rights or licenses with respect to the Products are granted or deemed granted under this Agreement or in connection herewith,
other than those rights expressly granted in this Agreement. 
 2.7 All distribution agreements heretofore entered into between
El En and Cynosure (collectively the “Prior Distribution Agreements”) are hereby terminated, except to the extent that (i) all rights, privileges and obligations of Cynosure with respect to Patents and Trademarks (as such terms are
defined in the Prior Distribution Agreements) shall continue in full force and effect to the extent necessary to service the Products sold prior to the date of termination, and (ii) Cynosure shall continue to have the right to provide service
and support to any purchaser of any Product sold by Cynosure pursuant to any Prior Distribution Agreement, including the right to sell or provide any Product or replacement part to any purchaser or user of any Product originally sold by Cynosure
pursuant to any Prior Distribution Agreement. For purposes of this Section 2.7, the term “Product” shall have the meanings assigned to such term in the Prior Distribution Agreements. 

  
 2 

	3.	OBLIGATIONS OF EL EN 

 3.1
El En shall provide such marketing and other sales support to Cynosure as the parties may agree from time to time provided that Cynosure shall pay for all travel, lodging, meals and related expenses incurred by El En in providing such support.

 3.2 El En reserves the right in its sole discretion to modify, alter, improve or change the Products. El En shall make
reasonable efforts to provide Cynosure with ninety (90) days’ prior written notice of any decision to change the Products, but any changes made for safety reasons or to accommodate regulatory requirements shall be effective upon notice to
Cynosure. 
 3.3 El En will provide annual training sessions (at locations to be determined by El En) for Cynosure sales and
service personnel at no cost to Cynosure. Notwithstanding the foregoing, Cynosure shall be responsible for all travel, lodging, meals and related expenses associated with attendance by its personnel at these training sessions. 

 

	4.	SALES TO CYNOSURE 

 4.1
Each order for the Products will be submitted by Cynosure on the Purchase Order form set forth at Exhibit B to this Agreement (hereinafter the “Purchase Order”) and will be processed by El En in a timely fashion. Each Purchase Order
submitted by Cynosure shall specify the quantity of the Products which Cynosure desires to purchase and the delivery date for such Product(s). The express terms of this Agreement, including the Purchase Order, supersede any contrary provisions in
any purchase order, agreement or other document used by Cynosure. Contracts for the sale of the Products by Cynosure to its customers shall automatically incorporate, to the extent applicable, the terms and conditions of this Agreement, including
the Purchase Order. El En will accept or reject each Purchase Order in writing within ten (10) working days after receipt from Cynosure. In the event that El En rejects a Purchase Order that is within the scope of the forecast provided by
Cynosure in accordance with Section 4.4, Cynosure shall have the right to terminate this Agreement unless El En accepts the Purchase Order within sixty (60) days of receipt of notice from Cynosure of its intent to terminate this Agreement

 4.2 Cynosure’s orders for the Products shall not be binding on El En until accepted by El En and may be canceled by
Cynosure only until that time. Orders shall be deemed accepted by El En when Cynosure is so notified in writing by El En. In the event of a shortage of the Products, El En will make reasonable efforts to make up such shortage as soon as is
commercially possible, but El En shall have no liability to Cynosure whatsoever as the result of its inability to meet Cynosure’s orders for the Products. 
 4.3 The price applicable to the Products is set forth in Exhibit C to this Agreement. The price applicable to the Products may be changed by El En only upon reasonable notice (not less than thirty
(30) days) to Cynosure and no price increase shall exceed [**]% during any one year during the term of this Agreement and an aggregate of [**]% over the full term 

  
 3 

 
of this Agreement. Any change in the price of the Products will not apply to any orders for Products from Cynosure accepted in writing by El En prior to the effective date of such change. All
amounts under this Agreement shall be calculated and paid in U.S. Dollars. In the event of the occurrence of any unforeseen circumstances that materially affect the manufacturing cost of the Products, the Parties shall negotiate in good faith an
adjustment if the price of the Products. 
 4.4 Cynosure will deliver to El En, not later than the first day of each March,
June, September and December in each year during the term of this Agreement, a forecast of Cynosure’s anticipated requirements for the Products during the following calendar quarter, specifying quantities and shipment dates therefor. The
forecast shall not be binding upon Cynosure. Upon acceptance in writing of each forecast by El En, El En shall make reasonable commercial efforts to maintain sufficient inventory to fill Cynosure’s requirements based on such forecasts. Products
shall, however, only be shipped against purchase orders accepted by El En. 
 4.5 Cynosure shall examine each shipment of the
Products to determine whether any item or items included in the shipment are in short supply, defective or damaged. Within five (5) business days of receipt of the shipment, Cynosure shall notify El En in writing of any shortages, defects or
damage which Cynosure claims existed at the time of delivery and are not a result of shipping. Within twenty (20) days of receipt of such notice, El En will investigate the claim of shortage, defects or damage, and inform Cynosure of its
findings. If El.En. determines that a shortage, defect or damages existed at the time of delivery and was not a result of shipping, El En will promptly deliver replacement Product to Cynosure. Unless notice is given as provided in this
Section 4.5, Cynosure shall be deemed to have accepted each shipment of the Product and to have waived all claims for shortages, defects or damage. 
  

	5.	DISTRIBUTORSHIP OPERATIONS 

5.1 Cynosure agrees to use commercially reasonable efforts to sell the Products in the Territory and to promote, through Cynosure’s
own advertising and sales promotion activities, the purchase and use of the Products by customers located in the Territory. Cynosure agrees to establish a sales program for the Products that will include the following responsibilities: 

5.2.1 Cynosure shall maintain one or more sales offices in the Territory and shall use best efforts and devote such time as necessary to
sell and promote the sale of the Products in the Territory. Cynosure shall solely determine its hours of operation, its staffing for its offices, its employment policies and benefits and where and when to make sales calls. 

5.2.2. Cynosure shall ensure that all personnel whom Cynosure assigns to sell the Products are adequately trained on the Products to
provide a satisfactory level of sales service to customers and provide effective sales presentations and training in the use of the Products to customers. 

  
 4 

 5.3 Cynosure agrees to purchase from El En the minimum number of Products per year as set
forth in Exhibit D attached hereto and made a part hereof. In the event Cynosure fails to purchase at least the minimum number per year of any of the Products as set forth in Exhibit D, El. En. at its sole option and as its sole remedy, shall have
the right to terminate this Agreement for such Product or Products pursuant to Section 7 of this Agreement and receive a payment from Cynosure equal to the difference between the amount actually paid to El En for the Products shipped by El En
to Cynosure and the amount that Cynosure would have paid El En if Cynosure had sold the minimum number of Products in the applicable year. Cynosure or its agent will purchase and carry spare parts for the Products out of warranty in order to provide
a prompt service. Cynosure shall purchase from El En such special tools as necessary to service and repair the Products. 
 5.4
As security for the payment by Cynosure of the purchase price for Products ordered under this Agreement, Cynosure hereby grants to El En a purchase money security interest in all Products sold or delivered by El En to Cynosure or to third parties on
Cynosure’s behalf, whether presently or after-acquired, in any and all purchase contracts for Products entered into between Cynosure and a customer, in any and all payments for Products due and payable from Cynosure’s customers, and in any
and all proceeds from the sale or delivery of such Products collected by Cynosure. Cynosure agrees to execute all necessary documents and financing statements requested by El En in order to perfect and enforce such security interest. 

 

	6.	ADDITIONAL CYNOSURE OBLIGATIONS 

 6.1 Cynosure shall promptly report to El En all complaints and product problems communicated by customers with respect to the Products. Cynosure shall be responsible for providing El En with a written
report of all Products complaints and problems. Cynosure shall assist El En in complying with the then current Medical Device Reporting/Adverse Event/Product Problem Regulations promulgated and amended by the U.S. Food and Drug Administration
(“FDA”) and with any similar regulations in other jurisdictions worldwide, including, without limitation, with CE regulations in the European Union. To the extent applicable to relationships of this nature and required by either regulation
or El En for post-market Product surveillance, Cynosure shall be responsible for maintaining traceability of all Products purchased and resold by Cynosure. 
 6.2 Cynosure shall make no warranties or representations, whether oral or written, with respect to the Products, including without limitation, sales literature, without the prior written consent of El.
En., Cynosure shall accurately and completely represent the Products, and promote the Products in a manner consistent with its labeling, FDA cleared or approved indications, and FDA regulations and other applicable regulations worldwide. 

6.3 Cynosure shall, at its sole expense, comply with all the laws and regulations applicable to its operations and to its performance of
its obligations under this Agreement. 
 6.4 Except as provided in this Section 6.4 and in Section 6.10 (below), El En
does not grant to Cynosure any license or rights to any intellectual property of El En. El En 

  
 5 

 
hereby grants Cynosure the non-exclusive, non-sublicensable, and non-transferable right (i) to display EL EN trade names and Trademarks associated with the Products or any System
incorporating the SLT II Laser system and to enforce the Trademarks in the Territory; (ii) to practice the inventions of the Patent Rights, in both cases solely to the extent necessary for the exclusive distribution and exclusive sale of the
Products and Systems incorporating the SLT II Laser system in the Territory and necessary for the performance of its obligations under this Agreement. Upon termination of this Agreement, Cynosure shall terminate all use of such trade names and
trademarks and Patent Rights except to the extent necessary to enable Cynosure to provide service or support with respect to any Products. Cynosure shall not, directly or indirectly, infringe or contest the validity of or the title to any of the
copyrights, trademarks or trade names owned by El En or under which El En is licensed, or otherwise impair the interests of El En in such intellectual property. 
 6.5 Cynosure will conduct all of its business in its own name and in a manner consistent with its obligations under this Agreement. Cynosure will be solely responsible for the payment of all the expenses
of its office and activities and will be solely responsible for the acts and expenses of its employees and independent contractors, if any. Neither Cynosure nor any of its employees or consultants shall be considered to be employees of El En for any
purpose whatsoever, including, without limitation, social security, unemployment compensation, workers’ compensation, income tax withholding, or any other such taxes or obligations. Cynosure understands and agrees that it is solely responsible
for payment of all such taxes and obligations. 
 6.6 Nothing in this Agreement shall be construed to constitute either party as
a partner, employee, franchisee, or agent of the other party, nor shall either party have any authority to bind the other in any respect. Neither party has the power to make contracts in the name of the other or to incur any liabilities whatsoever
in the name of the other. Each party shall remain an independent contractor responsible only for its own actions. Neither party nor any of their respective employees or consultants shall be entitled to participate in any plans, arrangements, or
distributions of the other party under any pension, stock, bonus, profit sharing, medical plan, or any other benefit plans offered or provided to the employees or consultants of the other party. 

6.7 Cynosure represents and warrants that Cynosure’s execution of this Agreement and performance of its obligations under this
Agreement do not and will not contravene, violate or constitute a breach of, any law, rule, regulation or the provisions of any court order or contractual agreement or other obligation to which Cynosure is a party or by which it is bound. El En
represents and warrants that El En has the right to appoint Cynosure as its exclusive distributor for the Products as provided in this Agreement. 
 6.8 Cynosure represents and warrants that it shall not disclose, use, have used, make available to or transfer to El En any information, including without limitation, any data, concepts, formula or trade
secrets, which is proprietary or confidential to a third party. 
 6.9 At all times during the term of this Agreement or any
renewal thereof, Cynosure shall refrain from promoting or selling any system that incorporates any product that has substantially the same specifications as the Products or is substantially similar to the Products. 

  
 6 

 6.10 Cynosure shall have the right, at its sole expense, upon prior written authorization by
El.En. which will not be unreasonably withheld to institute suit for infringement of the Patent Rights and the Trademark(s), including the right to sue for past infringement, against any third party within the Territory (the “Patent or
Trademark Infringement Action”) and to recover damages for itself pursuant to Section 6.12 below, including money damages and all other remedies for any infringement that occurred prior to the effective date of this Agreement. To the
extent El En gives its prior written authorization to Cynosure to institute a Patent or Trademark Infringement Action pursuant to the preceding sentence, El En agrees that is shall be a party in such Patent or Trademark Infringement Action. Cynosure
shall keep El En informed on a current basis of the status and progress of any such Patent or Trademark Infringement Actions, including by promptly providing El En with copies of any and all pleadings as they become available to Cynosure or its
counsel. Any settlement of any such Patent or Trademark Infringement Action shall require El. En.’s prior written consent. Cynosure shall bear all the expenses of the Patent or Trademark Infringement Actions which it initiates pursuant hereto,
including El En’s reasonable attorneys’ fees and expenses. Moreover, should El En be named a party, or be a necessary party to any lawsuit maintained, or initiated by, or brought against Cynosure, El En agrees to be so named and to
cooperate with and to assist Cynosure to the extent necessary for Cynosure to conduct the lawsuit, provided that Cynosure shall pay El En’s reasonable costs, including without limitation El En’s reasonable attorneys fees and expenses.
Cynosure’s obligation to defend El En under this Agreement does not extend to any suit or countersuit against El En relating to products or causes of action unrelated to the Products exclusively distributed and/or exclusively sold by Cynosure
under this Agreement. 
 6.11 If Cynosure does not institute a Patent or Trademark Infringement Action against a third party
within one hundred (120) days after having notice of any infringement of the Patent Rights by a third party, El En may institute, at its sole discretion, such action, provided that Cynosure shall have the right to be kept informed on a current
basis of the status and progress of any such actions instituted by El En. El En agrees to bear all of Cynosure’s expenses, including without limitation Cynosure’s reasonable attorneys’ fees and costs that may result from any action
brought by El En. In no event shall El En seek to join Cynosure as a party to any such action, without the express written consent of Cynosure. 
 6.12 Any recovery of damages or other monetary compensation, including, without limitation, by way of settlement, deriving from any lawsuit instituted pursuant to paragraphs 6.10 and 6.11 hereof, shall be
apportioned between Cynosure and El En so that Cynosure shall receive [**] percent ([**])% and El En shall receive [**] percent ([**]%) of any such recovery , including any treble or punitive damages that are awarded, net of expenses incurred, and
of attorneys’ fees and expenses awarded in the legal action. Cynosure shall bear all risks relating to any Patent or Trademark Infringement Action it has commenced, including without limitation payment of any recovery or attorneys’ fees
and expenses that may be awarded or be payable to defendant(s). El En shall bear no other risk as a result of any Patent Infringement or Trademark Action Cynosure may start pursuant to Section 6.10

  
 7 

 
other than those relating to the title and quality of El En’s patents or trademarks. Cynosure shall not seek to recover, either directly or indirectly, from El En any expenses, including
without limitation any attorneys’ fees and expenses, Cynosure has incurred as result of any legal action, including any preliminary stages of such actions, pursuant to Sections 6.10 and 6.11. 

6.13. El En shall have the sole and exclusive right to maintain and/or to prosecute the Patent and Trademark Rights. 

 

	7.	TERM AND TERMINATION 

 7.1
This Agreement is effective on the Effective Date and shall continue in force for a period of seven (7) years unless sooner terminated as herein provided. This Agreement shall be automatically renewed for additional terms of one year each
unless either party shall have given notice of termination to the other party not less than six-months prior to the expiration of the initial term or an renewal term. 
 7.2 Either party may terminate this Agreement in the event (a) the other party commits a material breach of this Agreement, which breach remains uncured for a period of thirty (30) days
following written notice of such material breach; or (b) the other party becomes insolvent, fails generally to pay its debts as they become due, makes an assignment for the benefit of creditors, is the subject of any voluntary or involuntary
case commenced under the federal bankruptcy laws, as now constituted or hereafter amended (which, in the case of involuntary bankruptcy, is not dismissed within ninety (90) days), or of any other proceeding under other applicable laws of any
jurisdiction regarding bankruptcy, insolvency, reorganization, adjustment of debt or other forms of relief for debtors, has a receiver, trustee, liquidator, assignee, custodian or similar official appointed for it or for any substantial part of its
property, or is the subject of any dissolution or liquidation proceeding. Without limiting the generality of the foregoing, failure by Cynosure to make any payment due to El En under this Agreement, subject to applicable cure periods set forth in
this Section 7.2, shall constitute a material breach for purposes hereof and shall attribute to El En at its sole option, the right to revoke the exclusivity of Cynosure’s rights within the Territory or to terminate the Agreement.

 7.3 After termination or expiration of this Agreement, any amounts owed by one party to the other for transactions occurring
during the term of the Agreement shall be paid in accordance with this Agreement. El En shall have no obligation to Cynosure for any sales or other activities of Cynosure after termination or expiration of this Agreement, unless expressly agreed in
writing signed by both parties. 
 7.4 After termination or expiration of this Agreement, each Party shall return to the other
Party all copies of confidential and/or proprietary information previously disclosed by the other Party, and Cynosure shall remove and not thereafter use any advertisements, brochures and other items in its possession or under its control, that
contain El En’s trademarks and/or service marks. All rights and licenses granted to Cynosure under this Agreement and Prior Distribution Agreements shall terminate and revert back to El En

  
 8 

 
except to the extent that such rights and licenses are necessary to enable Cynosure to provide service or support with respect to any Product that has been distributed by Cynosure. El En agrees
that for a period of 5 years following any termination or expiration of this Agreement, it will continue to make available for purchase by Cynosure spare parts for the Products or replacement Products to enable Cynosure to provide service and
support with respect to the Products sold by Cynosure during the term of this Agreement. 
 7.5 The following provisions of this
Agreement shall survive the termination or expiration of this Agreement: Sections 6.4, 6.5, 7.3, 7.4, 8, 9, 11, 15 and 16. 
  

	8.	CONFIDENTIALITY 

 With
respect to any information disclosed by either Party to the other Party, which information is identified by the disclosing Party as confidential or proprietary at the time of disclosure, the receiving Party will treat such information as strictly
confidential, and use the same degree of care to protect such information as it as the receiving Party uses to protect its own highest level confidential information, which shall not be less than due care. All customer lists, customer files, market
and sales data, discounting and pricing data, competitive analyses, market potential information and Products information shall be deemed confidential and proprietary. Each Party agrees not to use for its own benefit, nor to disclose to third
parties, any such information received from the other Party during the term of this Agreement or thereafter. These restrictions shall not apply to information that (a) was in the possession of the receiving prior to its disclosure by the
disclosing Party; (b) at the time of disclosure is in the public domain, or which later becomes part of the public domain through no breach of the terms of this Agreement; (c) was received by the receiving Party from a source other than
the disclosing Party, who did not acquire such information directly or indirectly from the disclosing Party, (d) was independently developed by the receiving Party. 

 

	9.	FORCE MAJEURE 

 Neither
party shall be liable in any manner for failure or delay to fulfill all or part of this Agreement as the result of any act of God, governmental orders or restriction, war, threat of war, warlike conditions, acts of terror, hostilities, sanctions,
mobilization, blockade, embargo, detention, revolution, riot, looting, strike, lockout, labor action, accident, or any other causes or circumstances beyond the such party’s reasonable control. Upon the occurrence of a force majeure event, the
party suffering such event shall immediately provide written notice to the other party of the existence and details of such force majeure event and its anticipated duration. 

 

	10.	WAIVER OF BREACH 

 Failure
of either party to require performance of any term of this Agreement or the waiver by either party of any default under this Agreement shall not be deemed a waiver of any subsequent default nor of the provision of this Agreement allegedly breached
as a result of such default. 

  
 9 

	11.	GOVERNING LAWS 

 This
Agreement shall be governed by and construed in accordance with the laws of the State of New York, without reference to its principles of conflicts of laws. 
  

	12.	ASSIGNMENT 

 This
Agreement shall not be assignable by either Party hereto without the prior written consent of the non-assigning Party, 
  

	13.	NO CHANGES OF AGREEMENT VALID 

 No modification of this Agreement shall be valid or binding upon either Party without its written consent, which consent will not be unreasonably withheld. 

 

	14.	OTHER AGREEMENTS 

 Except
as otherwise provided in this Agreement, all prior oral or written agreements or understandings between the Parties with respect to the subject matter of this Agreement are hereby terminated, except for those agreements or understandings which, by
their nature, are intended to survive termination. 
  

	15.	NOTICES 

 All notices
pertaining to this Agreement shall be confirmed in writing, and shall be delivered to the Party concerned, by registered or certified mail, or by recognized overnight air courier service, to the address first set forth above. Either Party may change
its address for notice by written notice to the other Party. Notice is deemed effective upon actual receipt. 
  

	16.	DISPUTE RESOLUTION 

 Any
dispute or difference arising out of or relating to this Agreement or the breach of this Agreement shall be commenced in the Supreme Court of New York situated in New York City or in the United States District Court for the Southern District of New
York. The parties to this Agreement consent to such jurisdiction, agree that venue will be proper in such courts in any such matter, agree that New York is the most convenient forum for litigation in any such suit, action or proceeding, agree that
such courts shall have exclusive jurisdiction to resolve any such dispute or difference, and agree that a summons and complaint commencing a suit, action or proceeding in any such court shall be properly served and shall confer personal jurisdiction
upon a Person if served by registered or certified mail to the address specified with respect to such Person pursuant to Section 15. Each party hereto hereby agrees not to elect a trial by jury of any issue triable by jury, and waives any right
to trial by jury fully to the extent that any such right shall now or hereafter exist, with regard to this Agreement or any claim, counterclaim or other action arising in connection 

  
 10 

 
herewith. This waiver of right to trial by jury is given knowingly and voluntarily by each party and is intended to encompass individually each instance and each issue as to which the right to a
trial by jury would otherwise accrue. 
  

	17.	COUNTERPARTS/ENTIRE AGREEMENT 

 This Agreement may be executed in duplicate and when so executed, each executed copy shall be deemed an original. All Exhibits referenced in this Agreement are deemed incorporated by reference.

  

	18.	CAPTIONS 

 The captions in
this Agreement have been inserted for convenience of reference only, are not to be considered a part of this Agreement, and shall in no way modify or restrict any of the terms or provisions of this Agreement. 

IN WITNESS WHEREOF, the Parties have hereto caused this Agreement to be executed by their duly authorized representatives, as of the day
and year first above written. 
  

									
	EL. EN. S.p.A.	 		 	CYNOSURE, INC.
					
	By:	 	 /s/ Andrea Cangioli
	 		 	By:	 	 /s/ Michael R. Davin

	Name:	 	Andrea Cangioli	 		 	Name:	 	Michael R. Davin
	Title:	 	Concigliere Delegato	 		 	Title:	 	President and CEO

  
 11 

 Exhibit A 
 Specifications of the Products 
  
 

 
  

					
	 System Type
	  	Nd:YAG
	 Wavelength
	  	1064 nm	 	1320 nm
	 Pulse Width (max)
	  	500 μS	 	1000 μS
			
	 Power Output Options
	  	30 W	 	16W
	 Maximum Rep Rate
	  	40 Hz	 	40 Hz
	 Aiming Beam
	  	Red
	 Electrical Requirements
	  	230 VAC/16A
	 Size (H x H x D)
	  	37.4” x 19.7” x 25.6”
 (95 cm x 50 cm x 65 cm)

	 Weight
	  	220 lbs (100 kg)

  
 12 

 Specifications 

 

							
	 	  	 1064-nm Laser
	  	 1320-nm Laser
	  	 1440-nm Laser

	 Wavelength
	  	1064 nm	  	1320 nm	  	1440 nm
				
	 Type:
	  	Solid State Nd:YAG	  		  	
			
	 Method of Optical Output:
	  	Flexible optical fiber (600 μm and 100 μm diameter)	  	 800 micron sidelaze triplex

1000 micron sidelaze cellulaze

				
	 Power Output

Option Minimum and

Maximum
	  	2W min. 40 W max at 1064 nm	  	 1 W min, 24 W max at 120 nm
	  	1 W min, 15 W max at 1440 nm
				
	 Maximum Pulse Frequency:
	  	40 Hz	  	40 Hz	  	40 Hz/25 Hz (*)
				
	 Maximum Pulse Duration:
	  	500 μs at 1064 nm	  	1000 μs at 1320 nm	  	1000 μs at 1440 nm
				
	 Nominal Ocular Hazard

Distance
	  	24.6 m at 1064 nm	  	7.24 m at 1320 nm	  	1.0 m at 1440 nm
				
	 Safety Eyewear Required:
	  	 3 5.0 OD at 1064 nm
 DLB6 ILB8
	  	 3 4.0 OD at 1320 nm
 DLB6 ILB8
	  	 3 2.0 OD at 1400 nm
 DLB4 ILB4

			
	 Cooling Method:
	  	Self-contained, internal cooler	  	
				
	 Aiming Beam Laser Type:
	  	Diode	  		  	
				
	 Aiming Beam Wavelength:
	  	635 nm (red)	  		  	
				
	 Aiming Beam Maximum

Delivered Output Power:
	  	3.0 mW	  		  	
			
	 Electrical Requirements:
	  	230 Vac, 16 A, 50/60 Hz, single phase	  	
				
	 Dimensions
	  	 Height 38.6” (98 cm)

Width 16.5” (42 cm)
 Depth 35.5” (90
cm)
	  		  	
				
	 Weight
	  	100 kg (220 Lbs)	  		  	
				
	 SmartSense Motion Sensing
	  	Optional	  		  	
			
	 ThermaGuide

Temperature Sensing
	  	Optional ( CELLUZAZE )	  	

  

	(*)	The 40Hz frequency is not available for power higher than 10W. 

  
 13 

 Exhibit A1 
 Specifications of the Systems incorporating the SLT II 
 -SMARTLIPO TRI-PLEX Advanced Laser
Lipolysis System ....... 
  

							
	

	 System Type
	  	Nd:YAG
	 Wavelength
	  	1064nm	 	1320nm	 	1440nm
	 Pulse Width (Max)
	  	500μs	 	1000μs	 	1000μs
	 Power Output Options
	  	40W	 	24W	 	15W
	 Max Rep Rate
	  	40Hz	 	40Hz	 	25Hz
		  	MultiPlexing Options
		  	1064nm and 1320nm	 	1064nm and 1440nm
		  	500μs and 1000μs	 	500μs and 1000μs
		  	40Hz	 	40 Hz and 25Hz
		
	 Aming Beam
	  	Red
	 Electrical Requirements
	  	230 VAC/16A
	 Size (HxWxD)
	  	37.4” x 19.7” x 25.6”
 (95cm x 50cm x 65cm)

	 Weight
	  	220 lbs (100kg)

 -CELLULAZE Cellulite Laser Workstation 
  

			
	

	 Systems Type
	  	Nd:YAG
	 Wavelength
	  	1440nm
	 Pulse Width (Max)
	  	1000μs
	 Power Output Options
	  	10W
	 Max Rep Rate
	  	25Hz
		
	 Aming Beam
	  	Red
	 Electrical Requirements
	  	230 VAC/16A
	 Size (HxWxD)
	  	37.4” x 19.7” x 25.6”
 (95cm x 50 cm x 65 cm)

	 Weight
	  	220 lbs (100kg)

  
 14 

 Exhibit B 
 Form of Purchase Order 
 Purchase Order No. 

Date: 
  

			
	 TO:
	  	FROM:
		
	 El. En. S.p.A.
	  	Cynosure, Inc.
	 Via Baldanzese 17
	  	5 Carlisle Road
	 50041 Calenzano
	  	Westford, Massachusetts 01886
	 Firenze, Italy
	  	
		
	 Tel:
	  	Tel: 978-256-4200
	 Fax:
	  	Fax: 978-256-0469

 : 

Quantity of Product Ordered: 

Requested Delivery Date(s): 

Delivery Location: 
 Total Purchase
Price: $                     

Standard Conditions of Purchase are attached and are made part of this Purchase Order. 

  
 15 

 STANDARD CONDITIONS OF PURCHASE 

These conditions apply to the attached Purchase Order. 
 FORMATION OF CONTRACT 
 The Purchase Order is an offer by you to purchase from El. En.
S.p.A. the quantity of Product described in the Purchase Order. By submitting the Purchase Order to us, you agree to purchase the Product on the terms and conditions specified in the Purchase Order and these Standard Conditions of Purchase. We
accept your offer by the signature of a duly authorized officer of El. En. S.p.A. 
 The Purchase Order and these Standard Conditions of
Purchase (together with the Exclusive Distribution Agreement dated as of October 26, 2012 (the Distribution Agreement)) are intended to be the complete and exclusive statement of the terms of the contract between us. Please understand that our
acceptance of your offer is expressly made conditional on your assent to all of our terms. No prior proposals, statements, course of dealing or usage of the trade will be part of the contract. 

After the contract has been formed, it may be modified only by written document signed by our respective authorized representatives. No order accepted by
us may be terminated, canceled, modified or assigned by either Party without the other Party’s prior written permission. 
 PRICE AND
TAXES 
 The price you will pay is stated in the Purchase Order. The price includes the quantity of Product described in the Purchase Order,
standard packaging and shipping. You shall be responsible for all taxes on the Product (including without limitation any sales use, excise or similar tax), custom fees and duties, VAT and other related governmental fees and costs, transportation to
the site specified in the Purchase Order, special packaging and insurance. Any applicable taxes will be added to the price, unless we receive a tax exemption certificate from you which is acceptable to the taxing authorities. 

PAYMENT 
 The payment terms are as
follows: Net 30 days from shipment. Past due balances are subject to a service charge up to the maximum amount permitted by applicable law. If any payment depends on an event which is delayed for a reason for which you are responsible, you will make
the payment when the event was first scheduled to occur. 

  
 16 

 DELIVERY 
 We will not be not responsible for any delay in performance or delivery which is due to unforeseen circumstances, or to causes beyond our reasonable control, including, without limitation, strike,
lockout, riot, war, act of God, or compliance with any governmental law, regulation or order (including U.S. Export regulations), or any delay in vendors supplying materials and equipment. If such a delay occurs, we may extend the performance or
delivery date for a period of time equal to the delay. 
 TRANSPORTATION, TITLE AND RISK OF LOSS 

Except as otherwise provided below, all shipments are Ex Works: Calenzano, our manufacturing facility in Italy. You are responsible for all transportation
and insurance. Title and risk of loss or damage to the Product shall pass upon delivery to the shipper. 
 ACCEPTANCE OF PRODUCT

 You shall be responsible for examining each shipment of Product to determine whether any item or items included in the shipment are in
short supply, defective or damaged. Within five (5) business days of receipt of the shipment, you shall notify us in writing of any shortages, defects or damage which you claim existed at the time of delivery and are not a result of shipping.
Within twenty (20) days of receipt of such notice, we will investigate the claim of shortage, defects or damage, and inform you of our findings. If we determine that a shortage, defect or damages existed at the time of delivery and was not a
result of shipping, we will promptly deliver replacement Product to you. Unless notice is given as provided in this paragraph, you shall be deemed to have accepted each shipment of Product and to have waived all claims for shortages, defects or
damage. 
 LIMITED WARRANTY 
 We
warrant that the Product sold by us will not infringe any patents, trade secrets, trademarks, or other intellectual property rights of any third party, and that the Product, when delivered to you, shall be free from defects in materials and
workmanship for a period of one (1) year after receipt of the Product We make no warranty (express, implied or statutory) for any Product that is modified or subjected to unusual physical stress, misuse, improper storage or handling, or used in
any manner or medical procedure for which the Product is not indicated. We shall promptly replace any Product that fails to meet this limited warranty. This constitutes our sole liability to end users for breach of the foregoing warranty.

  
 17 

 EXCLUSIVITY AND DISCLAIMER 
 THE LIMITED WARRANTY IS EXCLUSIVE AND IN LIEU OF ALL OTHER WARRANTIES, EXPRESSED OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR
ANY IMPLIED WARRANTY ARISING OUT OF A COURSE OF DEALING OR OF PERFORMANCE, CUSTOM OR USAGE IN THE TRADE. YOUR EXCLUSIVE REMEDY FOR A DEFECT IN ANY PRODUCT SHALL BE THAT STATED IN THE LIMITED WARRANTY. 

LIMITATION OF LIABILITY 
 Our
responsibility for any claims, damages, losses or liabilities arising out of or related to our performance under the Purchase Order shall not exceed the aggregate consideration paid or payable to us pursuant to the Purchase Order. In addition, in no
event shall either party be liable to the other party, its employees or agents or to any other third party for any indirect, special, exemplary, incidental or consequential damages, including but not limited to damages resulting from loss of use,
loss of data, loss of profits or any harm or damage to persons or property arising out of or in connection with the Purchase Order or any equipment, materials or services provided under the Purchase Order. 

GENERAL MATTERS 
 Assignment. Any
assignment of the Purchase Order or these Standard Conditions of Purchase will be void without the other party’s prior written consent, which will not be unreasonably withheld, provided that either Party shall have the right to assign such
Purchase Order and these Standard Conditions of Purchase without the consent of the other Party in connection with a sale of its business to which this Purchase Order and these Standard Conditions of Purchase relates. 

Validity. If any provision of the Purchase Order or these Standard Conditions of Purchase is found invalid, the remaining portion will be
effective. 
 Governing Law. The Purchase Order and these Standard Conditions of Purchase are to be interpreted in accordance with, and
its administration and performance governed by, the laws of the State of New York without reference to its principles of conflicts of law. 

  
 18 

 Exhibit C 
 Product Pricing 
 The price for each Product is set forth below. Such price does not
include the taxes and other amounts specified in the form of Purchase Order. The price may be adjusted from time to time by El En as set forth in Section 4.3 of this Agreement. 

 

			
	SMARTLIPO MPX	  	US $ [**]                    
		
	SLT II Laser System	  	US $ [**]                    

  
 19 

 Exhibit D 
 Minimum Purchase Requirements 
  

			
	 	  	Products
	 Year 1
	  	[**]
	 Year 2
	  	[**]
	 Year 3
	  	[**]
	 Year 4
	  	[**]
	 Year 5
	  	[**]
	 Year 6
	  	[**]
	 Year 7
	  	[**]

  
 20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}]]